The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review
John Kanazawa(University of North Carolina at Chapel Hill), Karine Dubé(University of North Carolina at Chapel Hill), John A. Sauceda(San Francisco AIDS Foundation), Parya Saberi(University of California, San Francisco)
Cited by 64
Related Papers
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
|The Lancet HIV|2019|206
Team Structure and Culture Are Associated With Lower Burnout in Primary Care
|The Journal of the American Board of Family Medicine|2014|202
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
|Current Opinion in HIV and AIDS|2014|116
Multi-stakeholder consensus on a target product profile for an HIV cure
|The Lancet HIV|2020|79